Copy number variation and warfarin dosing: evaluation of CYP2C9, VKORC1, CYP4F2, GGCX and CALU. [electronic resource]
Producer: 20120717Description: 297-307 p. digitalISSN:- 1744-8042
- Aged
- Anticoagulants -- therapeutic use
- Aryl Hydrocarbon Hydroxylases -- genetics
- Calcium-Binding Proteins -- genetics
- Carbon-Carbon Ligases -- genetics
- Cohort Studies
- Cytochrome P-450 CYP2C9
- Cytochrome P-450 Enzyme System -- genetics
- Cytochrome P450 Family 4
- DNA Copy Number Variations -- drug effects
- Dose-Response Relationship, Drug
- Ethnicity -- genetics
- Exons
- Female
- Gene Deletion
- Gene Duplication
- Humans
- INDEL Mutation
- Male
- Mixed Function Oxygenases -- genetics
- Vitamin K Epoxide Reductases
- Warfarin -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.